KIORA PHARMACEUTICALS, INC. (KPHMW) Operating income 2018–2025
KIORA PHARMACEUTICALS, INC. (KPHMW) annual operating income history from SEC filings — each fiscal year as reported.
-$12.8MFY2025 · since FY2018: -$10.8M → -$12.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.8M | -384.5% |
| FY2024 | $4.5M | +135.8% |
| FY2023 | -$12.6M | -2.3% |
| FY2022 | -$12.3M | +13.5% |
| FY2021 | -$14.2M | -107.3% |
| FY2020 | -$6.9M | — |
| FY2018 | -$10.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KPHMW financial trends
KPHMW RevenueKPHMW Net incomeKPHMW Net marginKPHMW Gross profitKPHMW Gross marginKPHMW Operating marginKPHMW Operating cash flowKPHMW Free cash flowKPHMW Capital expendituresKPHMW Return on equityKPHMW Stock buybacksKPHMW Dividends paidKPHMW Total assetsKPHMW Total liabilitiesKPHMW Shareholders’ equityKPHMW overview →